Marc Guillaume Denis

13PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 22, 2026
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative review.

|Nov 14, 2025
Molecular minimal residual disease in resected non-small cell lung cancer: "flattening the curve".

Marc G Denis

|Mar 13, 2025
Absolute Quantification of Nucleotide Variants in Cell-Free DNA via Quantitative NGS: Clinical Application in Non-Small Cell Lung Cancer Patients.

Guillaume Herbreteau, Marie Marcq, Chloé Sauzay

|May 27, 2022
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of Literature.

Laurent Mathiot, Guillaume Herbreteau, Siméon Robin

|Nov 27, 2021
<i>STK11/LKB1</i> Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact.

Elvire Pons-Tostivint, Alexandre Lugat, Jean-François Fontenau

|Aug 27, 2021
MEM: An Algorithm for the Reliable Detection of Microsatellite Instability (MSI) on a Small NGS Panel in Colorectal Cancer.

Guillaume Herbreteau, Fabrice Airaud, Elise Pierre-Noël

Pageof 3

Frequent Collaborators

3 joint publications

Elvire Pons-Tostivint

2 joint publications

Audrey Vallée

1 joint publications

Guillaume Herbreteau

1 joint publications

Christophe Blanquart